{"id":818,"date":"2021-11-26T08:50:02","date_gmt":"2021-11-26T07:50:02","guid":{"rendered":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/?p=818"},"modified":"2021-11-26T08:55:35","modified_gmt":"2021-11-26T07:55:35","slug":"nou-informe-de-farmacovigilancia-sobre-vacunes-covid-19","status":"publish","type":"post","link":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/nou-informe-de-farmacovigilancia-sobre-vacunes-covid-19\/","title":{"rendered":"Nou Informe de Farmacovigil\u00e0ncia sobre Vacunes COVID-19"},"content":{"rendered":"<p>L&#8217;Agencia Espa\u00f1ola de medicamentos y Productos Sanitario (AEMPS) acaba de publicar el <a href=\"https:\/\/www.aemps.gob.es\/informa\/boletines-aemps\/boletin-fv\/2021-boletin-fv\/10o-informe-de-farmacovigilancia-sobre-vacunas-covid-19\/\">10e informe de Farmacovigil\u00e0ncia<\/a> sobre les vacunes que s&#8217;estan administrant per a la COVID-19. En la informaci\u00f3 que es pot consultar a trav\u00e9s de la p\u00e0gina web de l&#8217;AEMPS es presenten les dades de cada vacuna per separat. En aquest informe s&#8217;actualitza la informaci\u00f3 sobre q\u00fcestions de seguretat que s&#8217;estaven avaluant i dels quals en calia un posicionament. En destaquem:<img loading=\"lazy\" class=\" wp-image-825 alignright\" src=\"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-content\/uploads\/sites\/5\/2021\/11\/covid.jpg\" alt=\"\" width=\"392\" height=\"244\" \/><\/p>\n<ul>\n<li>S&#8217;actualitzen les dades de casos notificades a Espanya de miocarditis\/pericarditis relacionades amb les vacunes d&#8217;ARNm (Comirnaty i Spikevax).<\/li>\n<li>Despr\u00e9s de l&#8217;avaluaci\u00f3 de la informaci\u00f3 disponible, s&#8217;ha considerat que no hi ha evid\u00e8ncia suficient que alguna de les vacunes contra la COVID-19 s&#8217;associ\u00ef a la s\u00edndrome inflamat\u00f2ria multisist\u00e8mica, aix\u00ed com als trastorns menstruals en relaci\u00f3 amb la vacuna de Janssen (ja descartat per a les altres vacunes).<\/li>\n<li>S&#8217;ha identificat com a possible reacci\u00f3 adversa de la vacuna Vaxzevria, la trombosi de sinus venosos cerebrals sense trombocitop\u00e8nia.<\/li>\n<\/ul>\n<p>Fins al 14 de novembre de 2021, s&#8217;han administrat a Espanya 71.746.002 dosis de vacunes contra la COVID-19, i s&#8217;han registrat 50.824 notificacions d&#8217;efectes adversos. Els esdeveniments notificats m\u00e9s sovint continuen sent els trastorns generals (febre i dolor a la zona de vacunaci\u00f3), del sistema nervi\u00f3s (cefalea i marejos) i del sistema musculoesquel\u00e8tic (mi\u00e0lgia i artr\u00e0lgia).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>L&#8217;Agencia Espa\u00f1ola de medicamentos y Productos Sanitario (AEMPS) acaba de publicar el 10e informe de Farmacovigil\u00e0ncia sobre les vacunes que s&#8217;estan administrant per a la COVID-19. En la informaci\u00f3 que es pot consultar a trav\u00e9s de la p\u00e0gina web de &hellip; <a href=\"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/nou-informe-de-farmacovigilancia-sobre-vacunes-covid-19\/\">Continua llegint <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[19],"tags":[87,862,628,242,737],"_links":{"self":[{"href":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-json\/wp\/v2\/posts\/818"}],"collection":[{"href":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-json\/wp\/v2\/comments?post=818"}],"version-history":[{"count":5,"href":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-json\/wp\/v2\/posts\/818\/revisions"}],"predecessor-version":[{"id":826,"href":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-json\/wp\/v2\/posts\/818\/revisions\/826"}],"wp:attachment":[{"href":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-json\/wp\/v2\/media?parent=818"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-json\/wp\/v2\/categories?post=818"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/blogs.bellvitgehospital.cat\/farmacologiaclinica\/wp-json\/wp\/v2\/tags?post=818"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}